Global Humanized Liver Mice Model Market size was valued at USD 100.30 Mn. in 2024, and the total Humanized Liver Mice Model Market revenue is expected to grow by 6.8% from 2025 to 2032, reaching nearly USD 169.77 Mn.Humanized Liver Mice Model Market Overview
Humanized mouse models have emerged as a promising alternative to traditional animal models.The human liver serves as the reservoir for several important pathogens, which are responsible for more than half-a-billion infections and between 2.5 and 4.5 million deaths annually. The report covers the current estimate and forecast for Market on a global and regional level. The report provides an in-depth analysis of the Humanized Liver Mice Model Market for the period 2024 – 2030, wherein 2023 is the base year and the period from 2024 to 2030 is the forecast period. Data for 2018- 2023 has been included as historical information. The study provides a detail perspective on market growth, throughout the above forecast period in terms of revenue estimates (in US$ Mn), across different geographies, which includes North America (NA), Europe (EU), Asia Pacific (APAC), Middle East & Africa (MEA) and South America.To Know About The Research Methodology :- Request Free Sample Report The report provides qualitative and quantitative insights on the Humanized Liver Mice Model industry trends and detail analysis of market size and growth rate of all segment in the market. The global Humanized Liver Mice Model market is segmented by Application, and Region. Key Players Operated in Global Market are The Jackson Laboratory, Crown Bioscience Inc., Charles River Laboratories International Inc., Taconic Biosciences Inc., Ingenious Targeting Laboratory Inc., Trans Genic Inc. Ltd., GenOway, Creative Animodel, Horizon Discovery Group plc., Hera BioLabs, PhoenixBio Group, Beijing Vitalstar Biotechnology Co. Ltd., Yecuris Corporation.
Humanized Liver Mice Model Market Dynamics
Increased number of government funds for liver-based disease therapies have increased numbers in research and development activities which will boosting the global market in the forecast period. Advances in the generation and maintenance of humanized mice liver have made them more robust tools and have stimulated interest in using them as models for answering additional liver-specific questions.Many new genomic editing therapies under development, where humanized liver mice offer a unique testing environment for genomic editing therapy delivery methods, shows significant opportunities for global market.Humanized Liver Mice Model Market Segment Analysis
Based on Application, Pharmacokinetic Studies segment is expected to grow at a CAGR of xx% in the forecast period. Humanized transgenic mice are valuable animal models in understanding the significance of specific human drug-metabolizing enzymes in drug clearance and pharmacokinetics, as well as in predicting potential drug-drug interactions and chemical toxicity in humans. Human liver mice have been employed for preclinical evaluation of efficacy, toxicology, and pharmacokinetic profiles of small molecule drug candidates and biologicals, including antibodies targeting host and pathogen components. Preclinical evaluation of vaccine potency in mice engrafted with human tissues efficiently supporting various pathologies, and safety, efficacy, and pharmacokinetics studies of drugs and therapeutic biologicals. Drug metabolism profiles indicate that human liver mice models shows the useful results for predicting human drug interactions, as well as endogenous enzyme induction and inhibition, all of these reasons gives the growth opportunity for global humanized liver mice model making drug development. For example, mice with a human immune system and supplementary human lung tissue could model tuberculosis or cytomegalovirus (CMV) pathogenesis. Based on model type, Cell-based humanized liver mice models dominated the Humanized Liver Mice Model market because of their high physiological relevance and functionality, a liver response that closely mimics that in humans in vivo. The development of these models is typically via human hepatocyte transplantation into immunocompromised mice to characterize human liver-specific functions, drug metabolism, and toxicity to a greater degree than is possible with genetically humanized models. Humanized liver mice models can reproduce key processes within the liver (enzyme activity, drug-drug interactions, and viral inoculations), thus are ideal for pharmaceutical research and preclinical validation. The continued ability to acquire human hepatocytes and gain reasonable engraftments of hepatocytes also makes these models widely adopted across all drug development pipelines.Humanized Liver Mice Model Market Regional Insights
Europe is leading in the global market and maintain its steady position in the forecast period. High research facilities and implementation of research facilities in research organisations, especially in the life science is projected to grow the global market. Advances in genetic studies and large number of ongoing research on the humanized liver mice model, grow the global market in Europe economies. Development of new genetically engineered human liver model with advance technology is a key development, which make positive impact on global humanized liver mice model.Humanized Liver Mice Model Market Scope: Inquire before buying
Humanized Liver Mice Model Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 100.30 Mn. Forecast Period 2025 to 2032 CAGR: 6.8% Market Size in 2032: USD 169.77 Mn. Segments Covered: by Model type Genetic humanized liver mice Cell based humanized liver mice by Source of cells Human Hepatocytes Induced Pluripotent Cells by End User Pharmaceutical and Biotech Companies Academic and Research institutes Contract research organizations (CROs) by Application Pharmacokinetics Studies In-vivo Liver Toxicity Testing Drug Metabolism Studies Others Humanized Liver Mice Model Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Humanized Liver Mice Model Market, Key Players are
1. The Jackson Laboratory 2. Crown Bioscience Inc. 3. Charles River Laboratories International Inc. 4. Taconic Biosciences Inc. 5. Ingenious Targeting Laboratory Inc. 6. Trans Genic Inc. Ltd. 7. GenOway 8. Creative Animodel 9. Horizon Discovery Group plc. 10. Hera BioLabs 11. PhoenixBio Group 12. Beijing Vitalstar Biotechnology Co. Ltd. 13. Yecuris Corporation Frequently Asked Questions: 1. Which region has the largest share in Global Humanized Liver Mice Model Market? Ans: The Europe region held the highest share in 2024. 2. What is the growth rate of the Global Humanized Liver Mice Model Market? Ans: The Global Humanized Liver Mice Model Market is growing at a CAGR of 6.12% during the forecasting period 2025-2032. 3. What is the scope of the Global Humanized Liver Mice market report? Ans: Global Humanized Liver Mice Model Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in the Global Humanized Liver Mice Model market? Ans: The important key players in the Global Humanized Liver Mice Model Market are – The Jackson Laboratory, Crown Bioscience Inc., Charles River Laboratories International Inc., Taconic Biosciences Inc., Ingenious Targeting Laboratory Inc., Trans Genic Inc. Ltd., GenOway, Creative Animodel, Horizon Discovery Group plc., Hera BioLabs, PhoenixBio Group, Beijing Vitalstar Biotechnology Co. Ltd., Yecuris Corporation 5. What is the study period of the Humanized Liver Mice Model Market? Ans: The Global Humanized Liver Mice Model Market is studied from 2024 to 2032.
1. Humanized Liver Mice Model Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Humanized Liver Mice Model Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2024) 2.3.5. Company Locations 2.4. Leading Humanized Liver Mice Model Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Humanized Liver Mice Model Market: Dynamics 3.1. Humanized Liver Mice Model Market Trends by Region 3.1.1. North America Humanized Liver Mice Model Market Trends 3.1.2. Europe Humanized Liver Mice Model Market Trends 3.1.3. Asia Pacific Humanized Liver Mice Model Market Trends 3.1.4. Middle East and Africa Humanized Liver Mice Model Market Trends 3.1.5. South America Humanized Liver Mice Model Market Trends 3.2. Humanized Liver Mice Model Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Humanized Liver Mice Model Market Drivers 3.2.1.2. North America Humanized Liver Mice Model Market Restraints 3.2.1.3. North America Humanized Liver Mice Model Market Opportunities 3.2.1.4. North America Humanized Liver Mice Model Market Challenges 3.2.2. Europe 3.2.2.1. Europe Humanized Liver Mice Model Market Drivers 3.2.2.2. Europe Humanized Liver Mice Model Market Restraints 3.2.2.3. Europe Humanized Liver Mice Model Market Opportunities 3.2.2.4. Europe Humanized Liver Mice Model Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Humanized Liver Mice Model Market Drivers 3.2.3.2. Asia Pacific Humanized Liver Mice Model Market Restraints 3.2.3.3. Asia Pacific Humanized Liver Mice Model Market Opportunities 3.2.3.4. Asia Pacific Humanized Liver Mice Model Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Humanized Liver Mice Model Market Drivers 3.2.4.2. Middle East and Africa Humanized Liver Mice Model Market Restraints 3.2.4.3. Middle East and Africa Humanized Liver Mice Model Market Opportunities 3.2.4.4. Middle East and Africa Humanized Liver Mice Model Market Challenges 3.2.5. South America 3.2.5.1. South America Humanized Liver Mice Model Market Drivers 3.2.5.2. South America Humanized Liver Mice Model Market Restraints 3.2.5.3. South America Humanized Liver Mice Model Market Opportunities 3.2.5.4. South America Humanized Liver Mice Model Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Humanized Liver Mice Model Industry 3.8. Analysis of Government Schemes and Initiatives For Humanized Liver Mice Model Industry 3.9. Humanized Liver Mice Model Market Trade Analysis 3.10. The Global Pandemic Impact on Humanized Liver Mice Model Market 4. Humanized Liver Mice Model Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2024-2032 4.1. Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 4.1.1. Genetic humanized liver mice 4.1.2. Cell based humanized liver mice 4.2. Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 4.2.1. Human Hepatocytes 4.2.2. Induced Pluripotent Cells 4.3. Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 4.3.1. Pharmaceutical and Biotech Companies 4.3.2. Academic and Research institutes 4.3.3. Contract research organizations (CROs) 4.4. Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 4.4.1. Pharmacokinetics Studies 4.4.2. In-vivo Liver Toxicity Testing 4.4.3. Drug Metabolism Studies 4.4.4. Others 4.5. Humanized Liver Mice Model Market Size and Forecast, by Region (2024-2032) 4.5.1. North America 4.5.2. Europe 4.5.3. Asia Pacific 4.5.4. Middle East and Africa 4.5.5. South America 5. North America Humanized Liver Mice Model Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 5.1. North America Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 5.1.1. Genetic humanized liver mice 5.1.2. Cell based humanized liver mice 5.2. North America Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 5.2.1. Human Hepatocytes 5.2.2. Induced Pluripotent Cells 5.3. North America Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 5.3.1. Pharmaceutical and Biotech Companies 5.3.2. Academic and Research institutes 5.3.3. Contract research organizations (CROs) 5.4. North America Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 5.4.1. Pharmacokinetics Studies 5.4.2. In-vivo Liver Toxicity Testing 5.4.3. Drug Metabolism Studies 5.4.4. Others 5.5. North America Humanized Liver Mice Model Market Size and Forecast, by Country (2024-2032) 5.5.1. United States 5.5.1.1. United States Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 5.5.1.1.1. Genetic humanized liver mice 5.5.1.1.2. Cell based humanized liver mice 5.5.1.2. United States Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 5.5.1.2.1. Human Hepatocytes 5.5.1.2.2. Induced Pluripotent Cells 5.5.1.3. United States Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 5.5.1.3.1. Pharmaceutical and Biotech Companies 5.5.1.3.2. Academic and Research institutes 5.5.1.3.3. Contract research organizations (CROs) 5.5.1.4. United States Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 5.5.1.4.1. Pharmacokinetics Studies 5.5.1.4.2. In-vivo Liver Toxicity Testing 5.5.1.4.3. Drug Metabolism Studies 5.5.1.4.4. Others 5.5.2. Canada 5.5.2.1. Canada Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 5.5.2.1.1. Genetic humanized liver mice 5.5.2.1.2. Cell based humanized liver mice 5.5.2.2. Canada Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 5.5.2.2.1. Human Hepatocytes 5.5.2.2.2. Induced Pluripotent Cells 5.5.2.3. Canada Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 5.5.2.3.1. Pharmaceutical and Biotech Companies 5.5.2.3.2. Academic and Research institutes 5.5.2.3.3. Contract research organizations (CROs) 5.5.2.4. Canada Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 5.5.2.4.1. Pharmacokinetics Studies 5.5.2.4.2. In-vivo Liver Toxicity Testing 5.5.2.4.3. Drug Metabolism Studies 5.5.2.4.4. Others 5.5.3. Mexico 5.5.3.1. Mexico Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 5.5.3.1.1. Genetic humanized liver mice 5.5.3.1.2. Cell based humanized liver mice 5.5.3.2. Mexico Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 5.5.3.2.1. Human Hepatocytes 5.5.3.2.2. Induced Pluripotent Cells 5.5.3.3. Mexico Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 5.5.3.3.1. Pharmaceutical and Biotech Companies 5.5.3.3.2. Academic and Research institutes 5.5.3.3.3. Contract research organizations (CROs) 5.5.3.4. Mexico Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 5.5.3.4.1. Pharmacokinetics Studies 5.5.3.4.2. In-vivo Liver Toxicity Testing 5.5.3.4.3. Drug Metabolism Studies 5.5.3.4.4. Others 6. Europe Humanized Liver Mice Model Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 6.1. Europe Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 6.2. Europe Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 6.3. Europe Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 6.4. Europe Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 6.5. Europe Humanized Liver Mice Model Market Size and Forecast, by Country (2024-2032) 6.5.1. United Kingdom 6.5.1.1. United Kingdom Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 6.5.1.2. United Kingdom Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 6.5.1.3. United Kingdom Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 6.5.1.4. United Kingdom Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 6.5.2. France 6.5.2.1. France Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 6.5.2.2. France Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 6.5.2.3. France Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 6.5.2.4. France Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 6.5.3. Germany 6.5.3.1. Germany Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 6.5.3.2. Germany Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 6.5.3.3. Germany Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 6.5.3.4. Germany Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 6.5.4. Italy 6.5.4.1. Italy Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 6.5.4.2. Italy Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 6.5.4.3. Italy Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 6.5.4.4. Italy Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 6.5.5. Spain 6.5.5.1. Spain Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 6.5.5.2. Spain Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 6.5.5.3. Spain Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 6.5.5.4. Spain Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 6.5.6. Sweden 6.5.6.1. Sweden Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 6.5.6.2. Sweden Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 6.5.6.3. Sweden Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 6.5.6.4. Sweden Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 6.5.7. Austria 6.5.7.1. Austria Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 6.5.7.2. Austria Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 6.5.7.3. Austria Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 6.5.7.4. Austria Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 6.5.8. Rest of Europe 6.5.8.1. Rest of Europe Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 6.5.8.2. Rest of Europe Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 6.5.8.3. Rest of Europe Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 6.5.8.4. Rest of Europe Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 7. Asia Pacific Humanized Liver Mice Model Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 7.1. Asia Pacific Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 7.2. Asia Pacific Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 7.3. Asia Pacific Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 7.4. Asia Pacific Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 7.5. Asia Pacific Humanized Liver Mice Model Market Size and Forecast, by Country (2024-2032) 7.5.1. China 7.5.1.1. China Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 7.5.1.2. China Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 7.5.1.3. China Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 7.5.1.4. China Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 7.5.2. S Korea 7.5.2.1. S Korea Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 7.5.2.2. S Korea Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 7.5.2.3. S Korea Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 7.5.2.4. S Korea Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 7.5.3. Japan 7.5.3.1. Japan Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 7.5.3.2. Japan Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 7.5.3.3. Japan Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 7.5.3.4. Japan Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 7.5.4. India 7.5.4.1. India Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 7.5.4.2. India Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 7.5.4.3. India Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 7.5.4.4. India Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 7.5.5. Australia 7.5.5.1. Australia Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 7.5.5.2. Australia Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 7.5.5.3. Australia Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 7.5.5.4. Australia Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 7.5.6. Indonesia 7.5.6.1. Indonesia Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 7.5.6.2. Indonesia Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 7.5.6.3. Indonesia Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 7.5.6.4. Indonesia Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 7.5.7. Malaysia 7.5.7.1. Malaysia Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 7.5.7.2. Malaysia Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 7.5.7.3. Malaysia Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 7.5.7.4. Malaysia Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 7.5.8. Vietnam 7.5.8.1. Vietnam Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 7.5.8.2. Vietnam Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 7.5.8.3. Vietnam Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 7.5.8.4. Vietnam Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 7.5.9. Taiwan 7.5.9.1. Taiwan Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 7.5.9.2. Taiwan Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 7.5.9.3. Taiwan Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 7.5.9.4. Taiwan Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 7.5.10. Rest of Asia Pacific 7.5.10.1. Rest of Asia Pacific Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 7.5.10.2. Rest of Asia Pacific Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 7.5.10.3. Rest of Asia Pacific Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 7.5.10.4. Rest of Asia Pacific Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 8. Middle East and Africa Humanized Liver Mice Model Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 8.1. Middle East and Africa Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 8.2. Middle East and Africa Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 8.3. Middle East and Africa Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 8.4. Middle East and Africa Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 8.5. Middle East and Africa Humanized Liver Mice Model Market Size and Forecast, by Country (2024-2032) 8.5.1. South Africa 8.5.1.1. South Africa Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 8.5.1.2. South Africa Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 8.5.1.3. South Africa Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 8.5.1.4. South Africa Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 8.5.2. GCC 8.5.2.1. GCC Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 8.5.2.2. GCC Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 8.5.2.3. GCC Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 8.5.2.4. GCC Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 8.5.3. Nigeria 8.5.3.1. Nigeria Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 8.5.3.2. Nigeria Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 8.5.3.3. Nigeria Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 8.5.3.4. Nigeria Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 8.5.4. Rest of ME&A 8.5.4.1. Rest of ME&A Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 8.5.4.2. Rest of ME&A Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 8.5.4.3. Rest of ME&A Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 8.5.4.4. Rest of ME&A Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 9. South America Humanized Liver Mice Model Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 9.1. South America Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 9.2. South America Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 9.3. South America Humanized Liver Mice Model Market Size and Forecast, by End User(2024-2032) 9.4. South America Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 9.5. South America Humanized Liver Mice Model Market Size and Forecast, by Country (2024-2032) 9.5.1. Brazil 9.5.1.1. Brazil Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 9.5.1.2. Brazil Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 9.5.1.3. Brazil Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 9.5.1.4. Brazil Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 9.5.2. Argentina 9.5.2.1. Argentina Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 9.5.2.2. Argentina Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 9.5.2.3. Argentina Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 9.5.2.4. Argentina Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 9.5.3. Rest Of South America 9.5.3.1. Rest Of South America Humanized Liver Mice Model Market Size and Forecast, by Model type (2024-2032) 9.5.3.2. Rest Of South America Humanized Liver Mice Model Market Size and Forecast, by Source of cells (2024-2032) 9.5.3.3. Rest Of South America Humanized Liver Mice Model Market Size and Forecast, by End User (2024-2032) 9.5.3.4. Rest Of South America Humanized Liver Mice Model Market Size and Forecast, by Application (2024-2032) 10. Company Profile: Key Players 10.1. The Jackson Laboratory 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Crown Bioscience Inc. 10.3. Charles River Laboratories International Inc. 10.4. Taconic Biosciences Inc. 10.5. Ingenious Targeting Laboratory Inc. 10.6. Trans Genic Inc. Ltd. 10.7. GenOway 10.8. Creative Animodel 10.9. Horizon Discovery Group plc. 10.10. Hera BioLabs 10.11. PhoenixBio Group 10.12. Beijing Vitalstar Biotechnology Co. Ltd. 10.13. Yecuris Corporation 11. Key Findings 12. Industry Recommendations 13. Humanized Liver Mice Model Market: Research Methodology 14. Terms and Glossary
